New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
09:02 EDTAEZSAeterna Zentaris upgraded to Buy from Hold at MLV Equity
MLV Equity believes Aeterna Zentaris' pipeline drugs, AEZS-108 and AEZS-130, have substantial value and that DSMB recommendation on Perifosine in Q1 could act as a catalysts. Price target is $5.50.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 17, 2015
16:27 EDTAEZSAeterna Zentaris reports Q4 EPS 6c, consensus (16c)
The increase in net income for the three-month period ended December 31, as compared to the same period in 2013, is due largely to higher comparative net finance income, offset partially by higher comparative operating expenses and by lower net income from discontinued operations. The decrease in net income for the year ended December 31, as compared to the same period in 2013, is due largely to the higher loss from operations and to lower net income from discontinued operations, partially offset by higher comparative net finance income.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use